Skip to main content
. 2017 Mar 21;27(5):520–530. doi: 10.5301/ejo.5000952

TABLE I.

Responder analyses

CsA CE, n Vehicle, n
Planned responder analyses
In patients with moderate to severe DED 241 248
 Ocular discomfort responders = ≥25% improvement in VAS
 Complete responders = CFS score of 0
Post hoc responder analyses
In patients with CFS score ≥3 and OSDI score ≥23 at baseline 128 118
 CFS responders = ≥2 grades improvement
 OSDI responders = ≥30% improvement
 Co-responders = improvement of ≥2 grades in CFS and ≥30% in OSDI
In patients with CFS score of 4 at baseline 43 42
 CFS responders = ≥2 grades improvement
 Co-responders = improvement of ≥2 grades in CFS and ≥30% in OSDI
In patients with CFS score of 2 at baseline 83 93
 Complete responders = CFS score of 0

N reflects the number of patients included in the full analysis set.

CsA CE = 0.1% cyclosporine A cationic emulsion; CFS = corneal fluorescein staining; DED = dry eye disease; OSDI = ocular surface disease index; VAS = visual analogue scale.